Following the most recent tariff warnings, the Nifty pharma index dropped by 0.9%, with 15 out of 20 companies experiencing ...

Aurobindo Pharma Limited announced that the USFDA has completed pre-approval inspection (PAI) at Eugia Steriles Private ...

Indian drugmakers earn a significant share of revenue from the United States, the largest importer of Indian pharma products.

Indian shares edged higher Wednesday, as gains in heavyweight financials overshadowed the decline in pharma stocks triggered ...

Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

In a regulatory filing, the company stated that the inspection resulted in five procedural observations, which it plans to ...

Burgundy Private Hurun India 500 report values Reliance at Rs 17.5 lakh crore. TCS comes in second at Rs 16.1 lakh crore, and ...

Macquarie suggested a target price of Rs 7,400 for Divis Labs, Rs 1,500 for Suven Pharma, Rs 835 for Syngene and Rs 1,000 for ...

From Delhi's new CM announcement today to Trump's pharma tariff threat and Tesla's India plans — Here are the top 11 news ...

Indian benchmark equity indices, Sensex and Nifty, traded lower on Wednesday. On the sectoral front, the Nifty IT index declined over 1.2% as investors awaited the Federal Reserve's January meeting ...

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

Shares of Indian pharmaceutical companies slid 2% on Wednesday after U.S. President Donald Trump said he intends to impose ...